drugset
drugset / Trial / NCT01619566

Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed

NCT01619566 ↗

Phase 4 Withdrawn University of California, San Diego
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Subjects with Fibromyalgia who respond to Duloxetine have specific nerve fiber characteristics. This can be used to predict which future patients will respond to Duloxetine.

Timeline

Start
2012-06
Primary completion
2015-01
Completion
2015-01

Outcome

Outcome not reported

Stopped: “Sponsor related”

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral

Indications

fibromyalgia